abstract |
The present invention relates to new dihydropteridinones of the formula (I) n n n wherein the groups X, R 1 , R 2 , R 3 , R 4 , R 5 and R 7 have the meanings given in the claims and specification, the isomers thereof, processes and intermediates for preparing these dihydropteridinones as well as the use thereof as pharmaceutical compositions. |